Statement Of Financial Position [Abstract]

Egetis Therapeutics - Filing #678414

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Right-of-use assets
43,000,000 SEK
26,000,000 SEK
Cash and cash equivalents
3,033,000,000 SEK
1,277,000,000 SEK
1,440,000,000 SEK
Assets
7,602,000,000 SEK
5,611,000,000 SEK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
154,000,000 SEK
113,000,000 SEK
Retained earnings
1 266,5 SEK
9,396,000,000 SEK
Other reserves
167,000,000 SEK
61,000,000 SEK
Equity
154,000,000 SEK
1 780,0 SEK
1 266,5 SEK
5,456,000,000 SEK
167,000,000 SEK
5,062,000,000 SEK
9,396,000,000 SEK
113,000,000 SEK
61,000,000 SEK
1 428,4 SEK
5,270,000,000 SEK
7,458,000,000 SEK
13,000,000 SEK
1 262,8 SEK
87,000,000 SEK
Equity and liabilities
7,602,000,000 SEK
5,611,000,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.